Monografie
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Diss., 2013
- Identifier
-
1038152062
- Subject
-
Krebs; Onkologie; Hochschulschrift
- Contributor
-
Pan, Jie
Enders, Georg
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Monografie
Associated
- Pan, Jie
- Enders, Georg
Other Objects (12)
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Preclinical in vitro investigation to evaluate novel molecular targeted therapy options for neuroendocrine neoplasms
Pancreatic neuroendocrine tumor mouse models
Development of GIPR antagonistis for targeted radiotheraphy in neuroendocrine neoplasms
Neuroendocrine disrupters
Targeted and non-targeted metabolomics in a mouse model of Lesch-Nyhan syndrome
Peripheral neuroendocrine interaction
Mouse models and targeted therapies for RAS-driven tumours
Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models
Endocrine and neuroendocrine surgery
Neuroendocrine perspectives ; Vol. 9
Neuroendocrine perspectives ; Vol. 8
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Preclinical in vitro investigation to evaluate novel molecular targeted therapy options for neuroendocrine neoplasms
Pancreatic neuroendocrine tumor mouse models
Development of GIPR antagonistis for targeted radiotheraphy in neuroendocrine neoplasms
Neuroendocrine disrupters
Targeted and non-targeted metabolomics in a mouse model of Lesch-Nyhan syndrome
Peripheral neuroendocrine interaction
Mouse models and targeted therapies for RAS-driven tumours
Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models
Endocrine and neuroendocrine surgery
Neuroendocrine perspectives ; Vol. 9
Neuroendocrine perspectives ; Vol. 8
Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Preclinical in vitro investigation to evaluate novel molecular targeted therapy options for neuroendocrine neoplasms
Pancreatic neuroendocrine tumor mouse models
Development of GIPR antagonistis for targeted radiotheraphy in neuroendocrine neoplasms
Neuroendocrine disrupters
Targeted and non-targeted metabolomics in a mouse model of Lesch-Nyhan syndrome
Peripheral neuroendocrine interaction
Mouse models and targeted therapies for RAS-driven tumours
Identification of synergistic combinations of targeted cytostatic drugs and immunostimulatory antibodies in preclinical models
Endocrine and neuroendocrine surgery
Neuroendocrine perspectives ; Vol. 9